acetazolamide

11
Deskripsi umum: FI4 Sifat pisikokoimia: fi 4, USP 30 Gol. Obat, PIO n AHFS 2004 Indikasi: AHFs 2005, hal 855 n PIO Mek. Kerja a to Z drug fact 2003 Farmakokinetik: ahfs 2004 hal 885 Dosis: ahfs 2004 hal 855, pio Kontraindikasi: BNF 57, 2009, hal 592, mayler hal 654 ES & toksisitas: ES (BNF 57, 2009, hal 592-593) Interaksi Obat: A to Z Drug Facts, 2003 Contoh sediaan yg beredar dipasaran: AHFS 2004, hal 855 3.2. Pra formulasi Formula umum: sediaan : Zat aktif Pengisotonis Pelarut: NaOH (dibuat terpisah) WFI 3.3. Formulasi Formula sediaan: Fornas hal.5 Usulan Formula: sediaan: acetazolamidum 500 mg Pelarut: NaOH 3.4. Metode dan Pembuatan Sediaan A. Perhitungan Buat table: Nama zat aktif, delta TF, dan C (%), delta TF.C - Tonisitas Acetazolamide Penurunan titik beku:W: o,52-∆Tb x C/ 0,576= 0,52-0,13x10%/0,576= 0,900

Upload: diwan-ayu

Post on 19-Jan-2016

57 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: acetazolamide

Deskripsi umum: FI4Sifat pisikokoimia: fi 4, USP 30

Gol. Obat, PIO n AHFS 2004Indikasi: AHFs 2005, hal 855 n PIO Mek. Kerja a to Z drug fact 2003Farmakokinetik: ahfs 2004 hal 885Dosis: ahfs 2004 hal 855, pioKontraindikasi: BNF 57, 2009, hal 592, mayler hal 654ES & toksisitas: ES (BNF 57, 2009, hal 592-593)Interaksi Obat: A to Z Drug Facts, 2003

Contoh sediaan yg beredar dipasaran: AHFS 2004, hal 8553.2. Pra formulasiFormula umum: sediaan : Zat aktif Pengisotonis Pelarut: NaOH (dibuat terpisah)

WFI

3.3. FormulasiFormula sediaan: Fornas hal.5Usulan Formula: sediaan: acetazolamidum 500 mg Pelarut: NaOH

3.4. Metode dan Pembuatan Sediaan

A. PerhitunganBuat table: Nama zat aktif, delta TF, dan C (%), delta TF.C

- TonisitasAcetazolamidePenurunan titik beku:W: o,52-∆Tb x C/ 0,576= 0,52-0,13x10%/0,576= 0,900

NaOH pH 9.2; POH=4,8__[OH]=10-4.8__[NaOH]= 1/1 x [OH-]___M NaOH=0,0000158___mol NaOH=0,0000158 M x 5 ml=0,0000792 mmol__ massa NaOH= 7,924x10-5 mol x 40 = 0,0032

Page 2: acetazolamide

B. PenimbanganAkan dibuat sediaan injeksi acetalomide dengan kekuatan sediaan 500 mg sebanyak 500 vial

DAFTAR PUSTAKADitjen POM Departemen Kesehatan RI. 1995. Farmakope Indonesia. Edisi ke empat. Jakarta: Departemen Kesehatan RI.

Uni

Page 4: acetazolamide
Page 6: acetazolamide

AcetaZOLAMIDEDrug Information Provided by Lexi-Comp

Buy the Book

PDA Download

Update Me

E-mail alerts

The Merck Manual Minute

Print This Topic

This information has been developed and provided by an independent third-party

source. Merck & Co., Inc. does not endorse and is not responsible for the accuracy of

the content, or for practices or standards of non-Merck sources.

Medication Safety Issues

Sound-alike/look-alike issues:

AcetaZOLAMIDE may be confused with acetoHEXAMIDE

Page 7: acetazolamide

Search

Index Sections Symptoms

A B C D E F G H I

J K L M N O P Q R

S T U V W X Y Z

In This Topic

AcetaZOLAMIDE

Medication Safety Issues

Pronunciation

U.S. Brand Names

Generic Available

Canadian Brand Names

Pharmacologic Category

Pharmacologic Category Synonyms

Use: Labeled Indications

Audio Figures Photographs Sidebars Tables Videos

Page 8: acetazolamide

Use: Unlabeled/Investigational

Pregnancy Risk Factor

Pregnancy Considerations

Lactation

Contraindications

Warnings/Precautions

Adverse Reactions

Metabolism/Transport Effects

Drug Interactions

Storage

Reconstitution

Compatibility

Mechanism of Action

Page 9: acetazolamide

Pharmacodynamics/Kinetics

Dosage

Administration: Oral

Administration: I.M.

Administration: I.V.

Administration: I.V. Detail

Monitoring Parameters

Test Interactions

Dietary Considerations

Patient Education

Geriatric Considerations

Dental Health: Effects on Dental Treatment

Dental Health: Vasoconstrictor/Local Anesthetic Precautions

Page 10: acetazolamide

Mental Health: Effects on Mental Status

Mental Health: Effects on Psychiatric Treatment

Nursing: Physical Assessment/Monitoring

Dosage Forms

Pricing: U.S. (www.drugstore.com)

http://www.merckmanuals.com/professional/lexicomp/acetazolamide.html#N16C37